![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 22, 16730-16737, June 2, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Galectin-1 induces apoptosis of immature
thymocytes and activated T cells, suggesting that galectin-1 regulates
cell death in the thymus during selection and in the periphery
following an immune response. Although it is known that galectin-1
recognizes lactosamine (Gal-GlcNAc) as a minimal ligand, this
disaccharide is ubiquitously expressed on a variety of cell surface
glycoproteins. Thus, susceptibility to galectin-1 may be regulated by
the presentation of lactosamine on specific oligosaccharide structures
created by specific glycosyltransferase enzymes. The core 2
Expression of a Specific Glycosyltransferase Enzyme Regulates
T Cell Death Mediated by Galectin-1*
§,
Department of Pathology and Laboratory
Medicine, UCLA School of Medicine, Los Angeles, California 90095 and
¶ The Glycobiology Program, The Burnham Institute, La Jolla,
California 92037
-1,6-N-acetylglucosaminyltransferase (core 2 GnT)
creates a branched structure on O-glycans that can be
elongated to present multiple lactosamine sequences. In the thymus, the
core 2 GnT is expressed in galectin-1-sensitive thymocyte subsets. In
the periphery, an oligosaccharide epitope created by the core 2 GnT is
expressed on galectin-1-sensitive activated T-cells. In this report, we
demonstrate that expression of the core 2 GnT was necessary and
sufficient for galectin-1-induced death of murine T cell lines. In
addition, overexpression of the core 2 GnT in mice increased the
susceptibility of double positive thymocytes to galectin-1. These data
demonstrate that expression of a specific glycosyltransferase can
control susceptibility to galectin-1, suggesting that developmentally
regulated glycosyltransferase expression may be a mechanism to modulate
cell death during T cell development and function.
*
This work was supported in part by National Institutes of
Health Grants R37CA33000 (to M. F.) and R01AI40118 (to L. G. B.), Grant RPG-97-049-01 from the American Cancer Society (to L. G. B.),
and a Glycoscience Research Award from Neose Technologies (to
L. G. B.). Work performed in the Flow Cytometry Core Laboratory was
supported in part by the Jonsson Comprehensive Cancer Center Core Grant
NIH-CA16042.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Pathology
and Laboratory Medicine, UCLA School of Medicine, 10833 Le Conte Ave.,
Los Angeles, CA 90095. Tel.: 310-206-5985; Fax: 310-206-0657; E-mail:
lbaum@mednet.ucla.edu.
This article has been cited by other articles:
![]() |
S. Bi, L. A. Earl, L. Jacobs, and L. G. Baum Structural Features of Galectin-9 and Galectin-1 That Determine Distinct T Cell Death Pathways J. Biol. Chem., May 2, 2008; 283(18): 12248 - 12258. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Stowell, Y. Qian, S. Karmakar, N. S. Koyama, M. Dias-Baruffi, H. Leffler, R. P. McEver, and R. D. Cummings Differential Roles of Galectin-1 and Galectin-3 in Regulating Leukocyte Viability and Cytokine Secretion J. Immunol., March 1, 2008; 180(5): 3091 - 3102. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Tribulatti, J. Mucci, V. Cattaneo, F. Aguero, T. Gilmartin, S. R. Head, and O. Campetella Galectin-8 Induces Apoptosis in the CD4highCD8high Thymocyte Subpopulation Glycobiology, December 1, 2007; 17(12): 1404 - 1412. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Hernandez, J. Klein, S. J. Van Dyken, J. D. Marth, and L. G. Baum T-cell activation results in microheterogeneous changes in glycosylation of CD45 Int. Immunol., July 2, 2007; (2007) dxm053v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. F. Valenzuela, K. E. Pace, P. V. Cabrera, R. White, K. Porvari, H. Kaija, P. Vihko, and L. G. Baum O-Glycosylation Regulates LNCaP Prostate Cancer Cell Susceptibility to Apoptosis Induced by Galectin-1 Cancer Res., July 1, 2007; 67(13): 6155 - 6162. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Walzel, A. A. Fahmi, M. A. Eldesouky, E. F. Abou-Eladab, G. Waitz, J. Brock, and M. Tiedge Effects of N-glycan processing inhibitors on signaling events and induction of apoptosis in galectin-1-stimulated Jurkat T lymphocytes Glycobiology, December 1, 2006; 16(12): 1262 - 1271. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Camby, M. Le Mercier, F. Lefranc, and R. Kiss Galectin-1: a small protein with major functions Glycobiology, November 1, 2006; 16(11): 137R - 157R. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Hernandez, J. T. Nguyen, J. He, W. Wang, B. Ardman, J. M. Green, M. Fukuda, and L. G. Baum Galectin-1 Binds Different CD43 Glycoforms to Cluster CD43 and Regulate T Cell Death J. Immunol., October 15, 2006; 177(8): 5328 - 5336. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. V. Cabrera, M. Amano, J. Mitoma, J. Chan, J. Said, M. Fukuda, and L. G. Baum Haploinsufficiency of C2GnT-I glycosyltransferase renders T lymphoma cells resistant to cell death Blood, October 1, 2006; 108(7): 2399 - 2406. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Perone, A. T. Larregina, W. J. Shufesky, G. D. Papworth, M. L. G. Sullivan, A. F. Zahorchak, D. B. Stolz, L. G. Baum, S. C. Watkins, A. W. Thomson, et al. Transgenic galectin-1 induces maturation of dendritic cells that elicit contrasting responses in naive and activated T cells. J. Immunol., June 15, 2006; 176(12): 7207 - 7220. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Patnaik, B. Potvin, S. Carlsson, D. Sturm, H. Leffler, and P. Stanley Complex N-glycans are the major ligands for galectin-1, -3, and -8 on Chinese hamster ovary cells Glycobiology, April 1, 2006; 16(4): 305 - 317. [Abstract] [Full Text] [PDF] |
||||
![]() |
J M Ilarregui, G A Bianco, M A Toscano, and G A Rabinovich The coming of age of galectins as immunomodulatory agents: impact of these carbohydrate binding proteins in T cell physiology and chronic inflammatory disorders Ann Rheum Dis, November 1, 2005; 64(suppl_4): iv96 - iv103. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hagisawa, C. Ohyama, T. Takahashi, M. Endoh, T. Moriya, J. Nakayama, Y. Arai, and M. Fukuda Expression of core 2 {beta}1,6-N-acetylglucosaminyltransferase facilitates prostate cancer progression Glycobiology, October 1, 2005; 15(10): 1016 - 1024. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mucci, E. Mocetti, M. S. Leguizamon, and O. Campetella A Sexual Dimorphism in Intrathymic Sialylation Survey Is Revealed by the trans-Sialidase from Trypanosoma cruzi J. Immunol., April 15, 2005; 174(8): 4545 - 4550. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Matarrese, A. Tinari, E. Mormone, G. A. Bianco, M. A. Toscano, B. Ascione, G. A. Rabinovich, and W. Malorni Galectin-1 Sensitizes Resting Human T Lymphocytes to Fas (CD95)-mediated Cell Death via Mitochondrial Hyperpolarization, Budding, and Fission J. Biol. Chem., February 25, 2005; 280(8): 6969 - 6985. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Leppanen, S. Stowell, O. Blixt, and R. D. Cummings Dimeric Galectin-1 Binds with High Affinity to {alpha}2,3-Sialylated and Non-sialylated Terminal N-Acetyllactosamine Units on Surface-bound Extended Glycans J. Biol. Chem., February 18, 2005; 280(7): 5549 - 5562. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Amado, Q. Yan, E. M. Comelli, B. E. Collins, and J. C. Paulson Peanut Agglutinin High Phenotype of Activated CD8+ T Cells Results from de Novo Synthesis of CD45 Glycans J. Biol. Chem., August 27, 2004; 279(35): 36689 - 36697. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Stowell, M. Dias-Baruffi, L. Penttila, O. Renkonen, A. K. Nyame, and R. D. Cummings Human galectin-1 recognition of poly-N-acetyllactosamine and chimeric polysaccharides Glycobiology, February 1, 2004; 14(2): 157 - 167. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lanteri, V. Giordanengo, N. Hiraoka, J.-G. Fuzibet, P. Auberger, M. Fukuda, L. G. Baum, and J.-C. Lefebvre Altered T cell surface glycosylation in HIV-1 infection results in increased susceptibility to galectin-1-induced cell death Glycobiology, December 1, 2003; 13(12): 909 - 918. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Carlow, M. J. Williams, and H. J. Ziltener Modulation of O-Glycans and N-Glycans on Murine CD8 T Cells Fails to Alter Annexin V Ligand Induction by Galectin 1 J. Immunol., November 15, 2003; 171(10): 5100 - 5106. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dias-Baruffi, H. Zhu, M. Cho, S. Karmakar, R. P. McEver, and R. D. Cummings Dimeric Galectin-1 Induces Surface Exposure of Phosphatidylserine and Phagocytic Recognition of Leukocytes without Inducing Apoptosis J. Biol. Chem., October 17, 2003; 278(42): 41282 - 41293. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. R. Falkenberg, K. Alvarez, C. Roman, and N. Fregien Multiple transcription initiation and alternative splicing in the 5' untranslated region of the core 2 {beta}1-6 N-acetylglucosaminyltransferase I gene Glycobiology, June 1, 2003; 13(6): 411 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Moody, S. J. North, B. Reinhold, S. J. Van Dyken, M. E. Rogers, M. Panico, A. Dell, H. R. Morris, J. D. Marth, and E. L. Reinherz Sialic Acid Capping of CD8beta Core 1-O-Glycans Controls Thymocyte-Major Histocompatibility Complex Class I Interaction J. Biol. Chem., February 21, 2003; 278(9): 7240 - 7246. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Amano, M. Galvan, J. He, and L. G. Baum The ST6Gal I Sialyltransferase Selectively Modifies N-Glycans on CD45 to Negatively Regulate Galectin-1-induced CD45 Clustering, Phosphatase Modulation, and T Cell Death J. Biol. Chem., February 21, 2003; 278(9): 7469 - 7475. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Hernandez and L. G. Baum Ah, sweet mystery of death! Galectins and control of cell fate Glycobiology, October 1, 2002; 12(10): 127R - 136R. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Rabinovich, N. Rubinstein, and L. Fainboim Unlocking the secrets of galectins: a challenge at the frontier of glyco-immunology J. Leukoc. Biol., May 1, 2002; 71(5): 741 - 752. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mucci, A. Hidalgo, E. Mocetti, P. F. Argibay, M. S. Leguizamon, and O. Campetella Thymocyte depletion in Trypanosoma cruzi infection is mediated by trans-sialidase-induced apoptosis on nurse cells complex PNAS, March 19, 2002; 99(6): 3896 - 3901. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kuwabara, Y. Kuwabara, R.-Y. Yang, M. Schuler, D. R. Green, B. L. Zuraw, D. K. Hsu, and F.-T. Liu Galectin-7 (PIG1) Exhibits Pro-apoptotic Function through JNK Activation and Mitochondrial Cytochrome c Release J. Biol. Chem., January 25, 2002; 277(5): 3487 - 3497. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Nguyen, D. P. Evans, M. Galvan, K. E. Pace, D. Leitenberg, T. N. Bui, and L. G. Baum CD45 Modulates Galectin-1-Induced T Cell Death: Regulation by Expression of Core 2 O-Glycans J. Immunol., November 15, 2001; 167(10): 5697 - 5707. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Pace, H. P. Hahn, M. Pang, J. T. Nguyen, and L. G. Baum Cutting Edge: CD7 Delivers a Pro-Apoptotic Signal During Galectin-1-Induced T Cell Death J. Immunol., September 1, 2000; 165(5): 2331 - 2334. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |